vTv Therapeutics is a startup based in the United States.
vTv Therapeutics is a company headquartered in the United States.
vTv Therapeutics is a late-stage biopharmaceutical company developing oral small molecule drugs to treat diabetes and other chronic diseases, with a lead candidate cadisegliatin aimed at an oral adjunctive therapy for type 1 diabetes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.